Literature DB >> 19629563

A nationwide study on topography and efficacy of the stroke treatment network in the Czech republic.

Robert Mikulík1, Daniel Václavík, Daniel Sanák, Michal Bar, Pavel Sevcík, Zbynek Kalita, Nils Wahlgren.   

Abstract

The SITS (Safe Implementation of Thrombolysis in Stroke)-EAST project was launched in 2007 to support evidence-based stroke treatments, including thrombolytic treatments (TLTs), in Central and Eastern Europe. The aim of this study was to detail the topography, efficacy, and specific characteristics of stroke centers in the Czech Republic (CZ), the country with the highest rate of TLT. The nationwide study was performed between September and November 2007 through a questionnaire sent to all centers registered in SITS. The questionnaire contained 25 questions addressing how centers met recommendations for primary and comprehensive stroke centers in 2006. Center characteristics predicting the number of TLTs were identified by multiple regression analysis. Altogether, data were obtained from 42 centers (88% response rate) with the following characteristics [median (min-max)]: catchment area population 150,000 (90,000-750,000); number of strokes/year 420 (150-1,589); number of TLTs 7.5 (2-45); number of physicians specialized in stroke 3 (1-7). Centers treated 4.3% of the patients with ischemic strokes with tissue plasminogen activator. A stroke unit was present in 32 (78%) departments. Rescue interventional therapies were performed in 11 (26%). Financial problems restricted TLT in 14 (35%) centers. Fourteen factors were associated with the number of TLTs in univariate regression analysis, but in multiple regression analysis, only the catchment area population (p < 0.001), >3 physicians specialized in stroke (p < 0.001), and the presence of an acute interventional program (p < 0.006) remained significant. This study provides the fundamental stroke treatment network data that are essential for certification and further SITS-EAST TLT expansion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19629563     DOI: 10.1007/s00415-009-5259-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  15 in total

1.  Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition.

Authors:  Mark J Alberts; Richard E Latchaw; Warren R Selman; Timothy Shephard; Mark N Hadley; Lawrence M Brass; Walter Koroshetz; John R Marler; John Booss; Richard D Zorowitz; Janet B Croft; Ellen Magnis; Diane Mulligan; Andrew Jagoda; Robert O'Connor; C Michael Cawley; J J Connors; Jean A Rose-DeRenzy; Marian Emr; Margo Warren; Michael D Walker
Journal:  Stroke       Date:  2005-06-16       Impact factor: 7.914

2.  Why are eligible thrombolysis candidates left untreated?

Authors:  Nancy K Hills; S Claiborne Johnston
Journal:  Am J Prev Med       Date:  2006-11-07       Impact factor: 5.043

3.  Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group.

Authors:  S C Fagan; L B Morgenstern; A Petitta; R E Ward; B C Tilley; J R Marler; S R Levine; J P Broderick; T G Kwiatkowski; M Frankel; T G Brott; M D Walker
Journal:  Neurology       Date:  1998-04       Impact factor: 9.910

4.  Prioritizing interventions to improve rates of thrombolysis for ischemic stroke.

Authors: 
Journal:  Neurology       Date:  2005-02-22       Impact factor: 9.910

5.  Economic benefit of increasing utilization of intravenous tissue plasminogen activator for acute ischemic stroke in the United States.

Authors:  Bart M Demaerschalk; Todd R Yip
Journal:  Stroke       Date:  2005-10-13       Impact factor: 7.914

Review 6.  Recommendations for the establishment of primary stroke centers. Brain Attack Coalition.

Authors:  M J Alberts; G Hademenos; R E Latchaw; A Jagoda; J R Marler; M R Mayberg; R D Starke; H W Todd; K M Viste; M Girgus; T Shephard; M Emr; P Shwayder; M D Walker
Journal:  JAMA       Date:  2000-06-21       Impact factor: 56.272

7.  Do the Brain Attack Coalition's criteria for stroke centers improve care for ischemic stroke?

Authors:  V C Douglas; D C Tong; L A Gillum; S Zhao; L M Brass; J Dostal; S C Johnston
Journal:  Neurology       Date:  2005-02-08       Impact factor: 9.910

8.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

9.  Calling 911 in response to stroke: a nationwide study assessing definitive individual behavior.

Authors:  Robert Mikulík; Laura Bunt; Daniel Hrdlicka; Ladislav Dusek; Daniel Václavík; Jirí Kryza
Journal:  Stroke       Date:  2008-04-24       Impact factor: 7.914

10.  Hospital volume and stroke outcome: does it matter?

Authors:  G Saposnik; A Baibergenova; M O'Donnell; M D Hill; M K Kapral; V Hachinski
Journal:  Neurology       Date:  2007-07-18       Impact factor: 9.910

View more
  1 in total

1.  Interrater variability for CT angiography evaluation between neurologists and neuroradiologist in acute stroke patients.

Authors:  Michal Bar; Jiri Kral; Tomas Jonszta; Vaclav Marcian; Martin Kuliha; Robert Mikulik
Journal:  Br J Radiol       Date:  2017-01-24       Impact factor: 3.039

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.